Zetia keeps your body from absorbing cholesterol in your diet, and it is generally safe and well-tolerated. So, it’s a good ...

The new cholesterol-lowering drug Crestor has more potentially harmful side effects than similar drugs and should be taken off the market, according to a lengthy correspondence published in today ...

Crestor and Lipitor also help prevent heart attacks and strokes. While they’re primarily used in adults, both are approved to treat high cholesterol in children with inherited conditions.

Not so the consumer advocacy group Public Citizen, which has waged a campaign to have Crestor taken off the market. In a citizen's petition to the Food and Drug Administration, the group said 29 ...

In the statin wars, there's little question that AstraZeneca's cholesterol-lowering drug Crestor is the most powerful when it comes to lowering LDL, the bad cholesterol, and giving a boost to good ...

The cholesterol drug Crestor goes generic this year. Consumer Reports looks into why some people may not see big savings on generic Crestor.

Despite government assurances that the popular cholesterol-lowering drug Crestor is safe, a new study has raised questions about the medication, saying it produces double the adverse reactions of ...

June 15, 2004 -- Safety problems with the widely used cholesterol drug Crestor have prompted European regulators to tighten prescription guidelines, but experts warn U.S. physicians may not be ...

But the availability of the generic forms of these drugs will also have an impact on physician prescribing habits and even drugs not yet on the market.

Crestor, Senay continues, is a much newer drug than Lipitor and Zocor, having only been on the market a little over a year. The first statin hit the market in 1987, and Lipitor, the most popular ...

Crestor was more effective at reducing coronary artery plaques - but the results were not statistically significant. That means they could have occurred by chance.

The cholesterol drug Crestor is being relabeled to add a warning that starter doses should be reduced in Asian-Americans and some other patients.